Zynex Receives FDA Clearance for its Next Generation NMES Device
Zynex, Inc. (ZYXI)
NASDAQ:AMEX Investor Relations:
zynexmed.com/ir-overview
Company Research
Source: PR Newswire
ENGLEWOOD, Colo., Feb. 6, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has received clearance from the U.S. Food and Drug Administration ("FDA") for the next generation M-Wave Neuromuscular Electrical Stimulation ("NMES") device.NMES treatments have several uses, including aiding recovery from surgery, managing chronic conditions, and even enhancing exercise performance in healthy individuals.The M-Wave replaces its predecessor, the E-Wave, which has been fundamental in NMES treatments across the U.S. since 1998. The E-Wave was the most powerful and versatile muscle stimulation device on the market for over two decades and the M-Wave builds on that history of performance with a more intuitive design and additional functionality."The M-Wave introduces the next evolution in NMES devices,
Show less
Read more
Impact Snapshot
Event Time:
ZYXI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYXI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYXI alerts
High impacting Zynex, Inc. news events
Weekly update
A roundup of the hottest topics
ZYXI
News
- Zynex, Inc. (NASDAQ:ZYXI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Zynex, Inc. (NASDAQ: ZYXI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.MarketBeat
- Zynex Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Zynex Reports First Quarter 2024 Financial ResultsPR Newswire
- Investing in Zynex (NASDAQ:ZYXI) five years ago would have delivered you a 82% gain [Yahoo! Finance]Yahoo! Finance
ZYXI
Sec Filings
- 5/2/24 - Form 4
- 5/2/24 - Form 4
- 4/30/24 - Form 4
- ZYXI's page on the SEC website